LoginSignup
image de profil
Homer
@Simpson
2Sem.·

Homer J Simpson joins UFP Technologies and acquires 10 shares

16.09
UFP Technologies logo
UFP Technologies
Acheté x10 à 173,70 €
1 737,00 €
17
11 Commentaires
image de profil
B. T.@Aktienhauptmeister
2Sem.
@Simpson You've been really freaking out since you stopped your savings plan project 😂✌️
•
6
•
image de profil
Homer@Simpson
2Sem.
@Aktienhauptmeister 45k still have to come in so that the depot volume is the same size again 😂
•
1
•
Patschke6686@Patschke6686
2Sem.
@Simpson Do you want to have it all in right away or wait for lower prices in some cases?
••
image de profil
Homer@Simpson
2Sem.
@Patschke6686 let's see, I want to build up a few more positions and then see if any investment ideas come up 😂 I want to break the 400k again by the end of the year, if the stock market plays along 😂
•
1
•
Patschke6686@Patschke6686
2Sem.
@Simpson what do you think about $WKL? Also came back well
•
1
•
image de profil
Homer@Simpson
2Sem.
@Patschke6686 I once had a savings plan that really went under the wheels. I'll have to think about it - the figures are actually solid
•
1
•
Patschke6686@Patschke6686
2Sem.
@Simpson I thought so too, and I'm still planning good prospects. I'm also pretty much in the red here
••
image de profil
Tenbagger2024@Tenbagger2024
2Sem.
Good time to buy,
the share has been lagging behind for weeks.
•
3
•
image de profil
Tenbagger2024@Tenbagger2024
2Sem.
Do you already have anything from the pharmaceutical sector?
Otherwise perhaps, here are two quality stocks with a lot of growth.
The P/E ratios are falling.

$CORT

https://aktie.traderfox.com/visualizations/US2183521028/DI/corcept-therapeutics-inc


$CAMX

https://aktie.traderfox.com/visualizations/SE0007692850/FFM/camurus-ab
•
1
•
image de profil
Homer@Simpson
2Sem.
@Tenbagger2024 I've often made mistakes with pharma and lost money 😂, so I plan to avoid this sector for the time being 😂
••
image de profil
Tenbagger2024@Tenbagger2024
2Sem.
@Simpson
You can take a look.
Camurus combats addiction to synthetic drugs. Which is unfortunately on the increase.

Corcept increases the EbiT margin by 10% per year and has good profit growth.

Put it on your watch and keep an eye on it for a while
•
2
•
Participez à la conversation
S'inscrireConnexion